NYU's Tautomer-Predictor Skips Quantum Calculations and Flags 126 PDBbind Ligands: What the September 2026 Chemical Science Paper by Pan, Han, Han and Zhang Shows
Medicine Henry Quentir Medicine Henry Quentir

NYU's Tautomer-Predictor Skips Quantum Calculations and Flags 126 PDBbind Ligands: What the September 2026 Chemical Science Paper by Pan, Han, Han and Zhang Shows

Quentir Medicine Monitor

Evidence-based insights for quantum medicine.

A single hydrogen atom can sit in two places on the same drug molecule. When it moves, the pattern of single and double bonds shifts with it, and the molecule presents a different face to the protein it is meant to bind. Chemists call these interchangeable forms tautomers, and choosing the wrong one at the start of a computer-aided drug design project can distort the docking scores and free-energy estimates that follow.

A paper in the Royal Society of Chemistry journal Chemical Science, "Deep learning of tautomer stability from crystallographic proton positions" by Xiaolin Pan, Chao Han, Fengyang Han and Yingkai Zhang of New York University, published online in September 2026, attacks this problem with an unusual source of training data. The team mined hydrogen positions resolved in small-molecule crystal structures from the Cambridge Structural Database, built more than 1.1 million tautomeric states from them, and trained a graph neural network to predict tautomer stability directly from a molecule's two-dimensional structure. The authors state that the model needs no 3D conformers and no quantum-mechanical calculations, which is what makes it fast enough for structure-based drug discovery at library scale.

The quantum-medicine interest lies in what the network replaces. Quantum chemistry has long been the accurate but slow reference for deciding which tautomer a molecule prefers, and it is also one of the problems quantum computing companies cite when they pitch molecular simulation to pharmaceutical buyers. Here a classical model trained on experimental crystal data takes over a large part of that job on a single GPU node.

The results come from retrospective tests on public structure collections. The study screened no new compounds in the laboratory and involved no patients, and its training labels describe molecules in the crystal, which is a different environment from a protein pocket or blood plasma.

Read More